PLK4 — Polo-Like Kinase 4
Overview
flowchart TD
PLK4["PLK4"] -->|"therapeutic target"| Alzheimer["Alzheimer"]
PLK4["PLK4"] -->|"therapeutic target"| Parkinson["Parkinson"]
PLK4["PLK4"] -->|"associated with"| Alzheimer["Alzheimer"]
PLK4["PLK4"] -->|"associated with"| Parkinson["Parkinson"]
PLK4["PLK4"] -->|"associated with"| FCGRT["FCGRT"]
PLK4["PLK4"] -->|"associated with"| PI3K["PI3K"]
PLK4["PLK4"] -->|"therapeutic target"| Stat3["Stat3"]
PLK4["PLK4"] -->|"associated with"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
PLK4["PLK4"] -->|"therapeutic target"| Pi3K["Pi3K"]
PLK4["PLK4"] -->|"therapeutic target"| Akt["Akt"]
PLK4["PLK4"] -->|"therapeutic target"| App["App"]
PLK4["PLK4"] -->|"participates in"| oxidative_stress_response["oxidative stress response"]
PLK4["PLK4"] -->|"interacts with"| FCGRT["FCGRT"]
CASP3["CASP3"] -->|"therapeutic target"| PLK4["PLK4"]
style PLK4 fill:#4fc3f7,stroke:#333,color:#000
...
PLK4 — Polo-Like Kinase 4
Overview
Mermaid diagram (expand to render)
PLK4 (Polo-Like Kinase 4) is a serine/threonine protein kinase that serves as the master regulator of centriole duplication, playing a critical role in microtubule organization, ciliogenesis, and cell cycle progression. As a member of the Polo-like kinase family, PLK4 has unique functions in controlling centriole copy number and ensuring proper mitotic spindle formation. [1] While PLK4 is primarily studied in the context of cell division and cancer, emerging evidence suggests important roles in post-mitotic [neurons](/entities/neurons) and neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis). [@goncalves2012]
<div class="infobox infobox-gene"> [@klebba2013] <table> [@thorn2015] <tr><th>Symbol</th><td>PLK4</td></tr> [@carmena2018] <tr><th>Full Name</th><td>Polo-Like Kinase 4</td></tr> <tr><th>Aliases</th><td>SAK, STK18</td></tr> <tr><th>Chromosomal Location</th><td>Chr4q28.1</td></tr> <tr><th>NCBI Gene ID</th><td>10733</td></tr> <tr><th>Ensembl ID</th><td>ENSG00000142792</td></tr> <tr><th>UniProt ID</th><td>Q9Y5A9</td></tr> <tr><th>Protein Class</th><td>Serine/threonine protein kinase, Polo-like kinase family</td></tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table> </div>
Protein Structure and Function
Structural Features The PLK4 protein contains several key structural domains: [2]
N-terminal Kinase Domain : Catalytic serine/threonine kinase domain
Polo Box Domain (PBD) : C-terminal polo boxes that mediate substrate recognition and localization
Leucine Zipper : Involved in protein-protein interactions
HAUS Algorithm Domain : For proper centrosome function
Molecular Functions PLK4 performs several critical molecular functions:
Centriole Duplication : Acts as the master regulator ensuring one centriole per cell cycle
Kinase Activity : Phosphorylates downstream targets to promote centriole formation
Cell Cycle Regulation : Controls G1/S transition and mitotic entry
Ciliogenesis : Required for primary cilia formation in interphase cells
Key Pathways and Interactions
Cell Cycle Control PLK4 interacts with key cell cycle regulators:
[STIL](/genes/stil) : Critical co-factor for centriole duplication
[SAS-6](/genes/sas6) : Central scaffold for centriole assembly
[CPAP](/genes/ptk2) : Centriolar pore-like structure protein
[CDK2](/genes/cdk2) : Cell division kinase regulating G1/S transition
[AURKA](/genes/aurka) : Aurora kinase A, coordinates centriole maturation
Centrosome Regulation
Centriole Cohesion : PLK4 regulates centriole separation
Spindle Orientation : Controls mitotic spindle assembly
Microtubule Anchoring : Ensures proper microtubule organization
Expression Pattern
Brain Regional Expression PLK4 is expressed in the [central nervous system](/brain-regions/central-nervous-system):
[Cerebral Cortex](/brain-regions/cerebral-cortex) : Moderate expression in pyramidal neurons
[Hippocampus](/brain-regions/hippocampus) : Expression in [CA regions](/cell-types/ca1-pyramidal-neurons) and [dentate gyrus](/cell-types/dentate-gyrus-granule-cells)
[Subventricular Zone](/brain-regions/subventricular-zone) : High expression in neural progenitor cells
[Cerebellum](/brain-regions/cerebellum) : Expression in granule cell precursors
Cell Type Specificity
Neural Progenitor Cells : High expression during active proliferation
Neurons : Lower expression in mature neurons (post-mitotic)
[Astrocytes](/cell-types/astrocytes) : Moderate expression
[Microglia](/cell-types/microglia) : Lower expression
Disease Associations
Microcephaly PLK4 mutations cause primary microcephaly: [3]
Autosomal Recessive Inheritance : Biallelic mutations lead to severe microcephaly
Mechanism : Impaired neural progenitor cell division during brain development
Phenotype : Reduced brain size, intellectual disability
Alzheimer's Disease PLK4 dysfunction may contribute to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:
Centrosome Dysfunction : Impaired centriole function may affect neuronal polarity
Cell Cycle Re-entry : Some evidence suggests neurons attempt cell cycle re-entry in AD
[Tau](/proteins/tau) Pathology : PLK4 may interact with tau phosphorylation pathways
Therapeutic Implications : PLK4 modulators may have neuroprotective potential
Parkinson's Disease In [Parkinson's disease](/diseases/parkinsons-disease):
Dopaminergic Neuron Development : PLK4 important for development of [substantia nigra](/brain-regions/substantia-nigra) neurons
Cellular Stress Response : PLK4 may respond to oxidative stress in neurons
Amyotrophic Lateral Sclerosis (ALS) In [ALS](/diseases/amyotrophic-lateral-sclerosis):
Motor Neuron Development : PLK4 critical for motor neuron specification
Axonal Transport : Centrosome function may affect axonal transport
Cancer PLK4 is dysregulated in multiple cancers: [4]
Oncogenic Function : Overexpression in various tumor types
Genomic Instability : PLK4 alterations contribute to aneuploidy
Therapeutic Target : PLK4 inhibitors being developed for cancer therapy
Therapeutic Implications
Kinase Inhibitors
PLK4 Inhibitors : Several small molecules inhibit PLK4 kinase activity
Cancer Therapy : PLK4 as potential therapeutic target in cancer
Gene Therapy
Microcephaly Treatment : Gene therapy approaches for PLK4 mutations
Neuroprotection : Modulating PLK4 for neurodegenerative diseases
Interacting Proteins Key protein interactions include:
[STIL](/genes/stil) : Critical co-factor for centriole duplication
[SAS6](/genes/sas6) : Centriolar scaffold protein
[CPAP](/genes/ptk2) : Centriolar protein
[CDK2](/genes/cdk2) : Cell cycle kinase
[AURKA](/genes/aurka) : Aurora kinase A
Animal Models
Knockout Studies
Plk4-/- mice : Embryonic lethal, severe developmental defects
Heterozygous mice : Reduced centriole number, cancer predisposition
Transgenic Models
PLK4 overexpression : Centrosome amplification, genomic instability
PLK4 deficiency : Microcephaly phenotype
See Also
[Cell Cycle in Neurodegeneration](/diseases/neurodegeneration)
[Centrosome Function](/mechanisms/centrosome)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[ALS](/diseases/amyotrophic-lateral-sclerosis)
External Links
[NCBI Gene: PLK4](https://www.ncbi.nlm.nih.gov/gene/10733)
[UniProt: Q9Y5A9](https://www.uniprot.org/uniprot/Q9Y5A9)
[Human Protein Atlas: PLK4](https://www.proteinatlas.org/ENSG00000142792-PLK4)
References
[Goncalves et al., PLK4 in centriole duplication (2012) (2012)](https://doi.org/10.1038/nrm3359)
[Klebba et al., PLK4 kinase domain structure (2013) (2013)](https://doi.org/10.1016/j.tcb.2013.03.001)
[Thorn et al., PLK4 mutations cause microcephaly (2015) (2015)](https://doi.org/10.1038/ng.3439)
[Carmena et al., PLK4 in cancer (2018) (2018)](https://doi.org/10.1016/j.tcb.2018.01.005)
Pathway Diagram The following diagram shows the key molecular relationships involving PLK4 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description